Inflammation News and Research

RSS

Siemens Healthineers launches rapid antigen test for the detection of SARS-CoV-2

As society continues to navigate through the COVID-19 pandemic, there is a critical public health need to get ahead of the spread with a fast and simple testing for all.

From Siemens Healthineers 20 Oct 2020

Template for COVID-19 management in a rural health system

As the COVID-19 pandemic continues to challenge existing health networks, a new study published on the preprint server medRxiv in October 2020 reports on a strategy to address existing health care disparities in rural and urban areas of the USA. This should draw attention to the need for more such systems to ensure proper rural healthcare in the current and future pandemics.

20 Oct 2020

Androgen deprivation strategies could help mitigate SARS-CoV-2 infection

Since the beginning of the COVID-19 pandemic, researchers have noted that women are generally less severely affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This has led to the exploration into estrogen and androgens' role in the hyperinflammatory clinical phenotypes of COVID-19. A recent study published on the preprint server bioRxiv shows that drugs targeting androgens and TMPRSS2 inhibitors may potentially combat the pandemic.

20 Oct 2020

Adult stem cell-based lung organoid models emulate host immune response in fatal COVID-19

Recently, a team of researchers from the University of California San Diego and The Scripps Research Institute, CA, USA, showed that an integrated stem cell-based disease modeling and computational approach is crucial for simulating the host immune response in fatal COVID-19 patients.

19 Oct 2020

Scientists uncover important disease-fighting role for cells in the liver

Scientists at Scripps Research have uncovered an important disease-fighting role for cells called hepatocytes, which constitute most of the liver. The discovery could potentially be harnessed to develop new medicines for viral illnesses.

19 Oct 2020

Scientists discover key enzyme involved in the development of autoimmune diseases

Scientists affiliated with the Center for Research on Inflammatory Diseases (CRID http://crid.fmrp.usp.br), hosted by the University of São Paulo (USP) in Brazil, have discovered that an enzyme involved in key metabolic processes also plays a role in immune cell differentiation and hence in the development of autoimmune diseases.

19 Oct 2020

Melatonin may increase survival chances among intubated COVID-19 patients

Researchers at Columbia University in New York have conducted a study showing that patients with coronavirus disease 2019 (COVID-19) who require intubation and mechanical ventilation due to respiratory distress may benefit from treatment with the hormone melatonin.

19 Oct 2020

Temple researchers identify criteria to predict cytokine storm in COVID-19 patients

Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules - showers that sometimes escalate into a chaotic immune response known as a cytokine storm.

19 Oct 2020

Immunoglobulin M ACE2 autoantibodies associated with severe COVID-19

As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses the association of Immunoglobulin M (IgM) autoantibodies against the host receptor that binds severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe disease via vascular endothelial damage. This could help develop better therapies and prognostic criteria.

19 Oct 2020

Novel multimodal intervention improves physical fitness and cognitive function

Researchers studied the effects of a 12-week exercise regimen on 148 active-duty Air Force airmen, half of whom also received a twice-daily nutrient beverage that included protein; the omega-3 fatty acid, DHA; lutein; phospholipids.

19 Oct 2020

CBD could reduce lung damage caused by COVID-19

One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

19 Oct 2020

Study provides possible explanation for progressive course of multiple sclerosis in mice

People with multiple sclerosis gradually develop increasing functional impairment. Researchers at Karolinska Institutet in Sweden have now found a possible explanation for the progressive course of the disease in mice and how it can be reversed.

16 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

Scientists from the University of Sheffield and University of Manchester have been awarded £265,000 from the British Heart Foundation, to investigate the links between vascular dementia and heart disease, and test whether a drug currently used to treat arthritis could also be used as a treatment for vascular dementia.

16 Oct 2020

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

16 Oct 2020

Gene variants may provide clues to successful treatment of pediatric eosinophilic esophagitis

A group of three gene variants, commonly inherited together, may provide clues to more successful treatment of pediatric eosinophilic esophagitis (EoE), a chronic inflammation of the food pipe often confused with gastroesophageal reflux disease (GERD).

16 Oct 2020

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.

16 Oct 2020

Glutathione precursor improves multiple deficits associated with premature aging

Premature aging in people with HIV is now recognized as a new, significant public health challenge. Accumulating evidence shows that people with HIV who are between 45 to 60 years old develop characteristics typically observed in people without HIV that are more than 70 years of age.

15 Oct 2020

COVID-19 can cause sudden permanent hearing loss in rare cases

Many complications have been reported, including heart disease and prolonged respiratory issues in a group of people called “long-haulers.” Now, a new worrying finding shows that COVID-19 can cause sudden and irreversible hearing loss in patients.

15 Oct 2020

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring labeling changes for nonsteroidal anti-inflammatory drugs (NSAIDs).

15 Oct 2020

Inflammation News and Research

Siemens Healthineers launches rapid antigen test for the detection of SARS-CoV-2

Template for COVID-19 management in a rural health system

Androgen deprivation strategies could help mitigate SARS-CoV-2 infection

Adult stem cell-based lung organoid models emulate host immune response in fatal COVID-19

Scientists uncover important disease-fighting role for cells in the liver

Scientists discover key enzyme involved in the development of autoimmune diseases

Melatonin may increase survival chances among intubated COVID-19 patients

Temple researchers identify criteria to predict cytokine storm in COVID-19 patients

Immunoglobulin M ACE2 autoantibodies associated with severe COVID-19

Novel multimodal intervention improves physical fitness and cognitive function

CBD could reduce lung damage caused by COVID-19

Study provides possible explanation for progressive course of multiple sclerosis in mice

New tool can provide non-invasive decision support for NSCLC treatment

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

Gene variants may provide clues to successful treatment of pediatric eosinophilic esophagitis

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

Glutathione precursor improves multiple deficits associated with premature aging

COVID-19 can cause sudden permanent hearing loss in rare cases

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News